Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice

Publisher： Karger

E-ISSN： 1421-9913|72|1-2|95-102

ISSN： 0014-3022

Source： European Neurology, Vol.72, Iss.1-2, 2014-06, pp. : 95-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice

By  

European Neurology, Vol. 76, Iss. 5-6, 2016-10 ,pp. : 216-226

Karger

Access to resources Recommend Favorite

Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 271-279

Karger

Access to resources Recommend Favorite

Long-Term Safety from the Raltegravir Clinical Development Program

By  

Current HIV Research, Vol. 9, Iss. 1, 2011-01 ,pp. : 40-53

Bentham Science Publishers

Access to resources Recommend Favorite

Long‐term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas

By Palomba Stefano  

Human Reproduction, Vol. 19, Iss. 6, 2004-06 ,pp. : 1308-1314

Oxford University Press

Access to resources Recommend Favorite

Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine

By  

Current HIV Research, Vol. 7, Iss. 5, 2009-09 ,pp. : 526-532

Bentham Science Publishers

Access to resources Recommend Favorite